GSK Submits Final Data For Application To Market HPV Vaccine Cervarix In U.S.
GSK Submits Final Data For Application To Market HPV Vaccine Cervarix In U.S.
GlaxoSmithKline on Monday said it has submitted final data to FDA in support of its application to market the human papillomavirus vaccine Cervarix in the U.S., the AP/Forbes.com reports (AP/Forbes.com, 3/30).
What next?
Posting Komentar